Methylenedioxyhydroxyethylamphetamine

MDHOET
Clinical data
Other names3,4-Methylenedioxy-N-hydroxyethylamphetamine; MDOHET; MDHET; MDHEA; N-Hydroxyethyl-MDA
Routes of
administration		Oral
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown
Identifiers
  • 2-{[(2H-1,3-benzodioxol-5-yl)propan-2-yl]amino}ethan-1-ol
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H17NO3
Molar mass223.272 g·mol−1
3D model (JSmol)
  • C1=C2C(=CC=C1CC(C)NCCO)OCO2
  • InChI=1S/C12H17NO3/c1-9(13-4-5-14)6-10-2-3-11-12(7-10)16-8-15-11/h2-3,7,9,13-14H,4-6,8H2,1H3 X markN
  • Key:SCUUYKMQDUDNBP-UHFFFAOYSA-N X markN
 X markNcheckY (what is this?)  (verify)

MDHOET, also known as 3,4-methylenedioxy-N-hydroxyethylamphetamine or as N-hydroxyethyl-MDA, is a lesser-known drug and a substituted amphetamine. It is also the N-hydroxyethyl analogue of MDA.

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDHOET's dose as greater than 50 mg orally and its duration as unknown. MDHOET produced few to no effects.

Chemistry

Synthesis

The chemical synthesis of MDHOET has been described.

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.

See also

References

  1. 1 2 3 4 5 6 7 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
  2. ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.